Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies
Go back to Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies| (NASDAQ: AUTL) | Delayed: 2.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.11 | 52 Week High | $ | |||
| Open | $2.11 | 52 Week Low | $ | |||
| Day High | $2.11 | P/E | N/A | |||
| Day Low | $2.11 | EPS | $ | |||
| Volume | 618 | |||||

